AL
NVO

Agran Libbie’s Novo Nordisk NVO Stock Holding History

Agran Libbie’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,900
Closed -$231K – 125
2016
Q4 		$231K Sell
12,900
-4,250
-25% -$77K 0.06% 114
2016
Q3 		$357K Sell
17,150
-1,200
-7% -$29.8K 0.1% 90
2016
Q2 		$493K Buy
18,350
+600
+3% +$16.5K 0.12% 94
2016
Q1 		$481K Buy
17,750
+4,790
+37% +$128K 0.12% 92
2015
Q4 		$376K Buy
12,960
+5,250
+68% +$145K 0.1% 98
2015
Q3 		$209K Hold
7,710
– – 0.06% 113
2015
Q2 		$211K Sell
7,710
-90
-1% -$2.53K 0.05% 117
2015
Q1 		$208K Buy
+7,800
New +$180K 0.05% 132

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Agran Libbie's NVO Position: Q1 2017 in Review

Agran Libbie sold out of Novo Nordisk (NVO) in Q1 2017, closing a stake of 12,900 shares — an estimated $231K sold.

Agran Libbie first reported a position in NVO in Q1 2015 and held it in 8 quarters. The position peaked at $493K in Q2 2016. 463 funds tracked by Wall St. Rank hold NVO as of Q1 2017.

  • Agran Libbie reported no remaining Novo Nordisk position as of Q1 2017 after selling out during the quarter.
  • Agran Libbie sold 12,900 Novo Nordisk shares in Q1 2017, an estimated $231K.
  • Agran Libbie first reported a position in Novo Nordisk in Q1 2015 and held it in 8 quarters.
  • Agran Libbie's Novo Nordisk position peaked at $493K in Q2 2016.
  • 463 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2017.

Based on Agran Libbie's 13F filing for Q1 2017, filed 27 Apr 2017.